![FDA Approves Foundation Medicine's Liquid Biopsy Test as Companion Diagnostic for Novartis' Tabrecta FDA Approves Foundation Medicine's Liquid Biopsy Test as Companion Diagnostic for Novartis' Tabrecta](https://geneonline.news/en/wp-content/uploads/2021/07/FoundationOne-Liquid-CDx-P190032.png)
FDA Approves Foundation Medicine's Liquid Biopsy Test as Companion Diagnostic for Novartis' Tabrecta
![Foundation Medicine and Chugai Announce Partnership with National Cancer Center for the Use of FoundationOne®Liquid in the Third Stage of SCRUM-Japan | Business Wire Foundation Medicine and Chugai Announce Partnership with National Cancer Center for the Use of FoundationOne®Liquid in the Third Stage of SCRUM-Japan | Business Wire](https://mms.businesswire.com/media/20200212005980/en/773224/5/FMI_vertical-slate.jpg)
Foundation Medicine and Chugai Announce Partnership with National Cancer Center for the Use of FoundationOne®Liquid in the Third Stage of SCRUM-Japan | Business Wire
![Foundation Medicine Announces Collaboration with Merck KGaA, Darmstadt, Germany to Develop Companion Diagnostics for Selected Marketed and Pipeline Treatments | Business Wire Foundation Medicine Announces Collaboration with Merck KGaA, Darmstadt, Germany to Develop Companion Diagnostics for Selected Marketed and Pipeline Treatments | Business Wire](https://mms.businesswire.com/media/20230605005278/en/794671/23/FMI_horizontal.jpg)
Foundation Medicine Announces Collaboration with Merck KGaA, Darmstadt, Germany to Develop Companion Diagnostics for Selected Marketed and Pipeline Treatments | Business Wire
![Point32Health and Foundation Medicine Expand Access to Comprehensive Genomic Profiling for Members with Advanced Cancer | Business Wire Point32Health and Foundation Medicine Expand Access to Comprehensive Genomic Profiling for Members with Advanced Cancer | Business Wire](https://mms.businesswire.com/media/20230302005150/en/1727718/23/Foundationmedicine_p32h_logo_v2.jpg)
Point32Health and Foundation Medicine Expand Access to Comprehensive Genomic Profiling for Members with Advanced Cancer | Business Wire
![Foundation Medicine Enters Strategic Collaboration with Roche in the Field of Molecular Information in Oncology | Kleiner Perkins | Make History Foundation Medicine Enters Strategic Collaboration with Roche in the Field of Molecular Information in Oncology | Kleiner Perkins | Make History](https://cdn.sanity.io/images/ti7si9cx/production/027cc19cfe86f324fb5ec461e5b519bb58a0ea29-1500x750.jpg?w=1382)